News and Trends 24 Nov 2022 New Labiotech Health Awareness Days listings page Earlier this year, we added a page to the website with all of the global events and conferences taking place. It’s been very well received, and we’ve had plenty of… November 24, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 31 May 2024 Biotech career fairs in the U.S. you don’t want to miss …annual events and inviting speakers from different fields within the industry, without the extra costs of hiring a place to host the events, and more importantly, offering people from across… May 31, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 19 Jan 2017 I heard about these Hot Topics at JPM: Devices, Politics & Personalities Last week, I had the pleasure of attending one of the smaller satellite events of the JP Morgan biotech conference. Here are some of the day’s themes. The JP Morgan… January 19, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 18 Nov 2022 Novavax’ COVID-19 vaccine gets expanded authorization for booster in adults …grades) of solicited adverse events generally increased, with most events being mild to moderate in severity. Novavax’ vaccine has been authorized as a heterologous and homologous booster in the U.S.,… November 18, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jul 2017 From Rockets to DNA – From SpaceX to CRISPR …the case of CRISPR, off-target events are minimized, whilst on-target events increase dramatically One major challenge is to get people to move away from outdated processes. Scientists are notoriously dogmatic… July 3, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Inside Labiotech 12 Feb 2019 Why We Love Being the Main Media Partner of BIO-Europe …organize great events and are always professional. Most importantly, their events are always fun and provide amazing networking opportunities. They bring together great people from the industry for a mix… February 12, 2019 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2025 Pushing biotech forward in France: 18 companies to know about …therapies for acute cardiovascular events Polygon Therapeutics is a French biotech company developing therapies that target the immune system’s role in acute cardiovascular events, particularly myocardial infarction (MI). Its lead… June 10, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 13 Nov 2024 Sleep apnea: biotechs snore points in the therapeutic space …the severity of sleep apnea. In the SURMOUNT-OSA Study 1, which tested the drug on patients not using CPAP machines, tirzepatide had a mean reduction from baseline of 27.4 events… November 13, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 8 Dec 2022 Enhertu’s positive results demonstrate improvement in overall survival …or pneumonitis events were low grade (grade 1 or grade 2) with two grade 3 events and no grade 4 or grade 5 events observed in patients treated with Enhertu…. December 8, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 Lutris Pharma radiation trial brings positive results for breast cancer patients …12 weeks and the data showed that LUT014 was generally well tolerated, no severe or serious adverse events occurred and no adverse events were associated with discontinuation of the study… September 8, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jun 2023 Head and neck cancer data presented at ASCO 2023 …and ISA101b was generally well tolerated with a safety profile resembling that of anti-PD-1 monotherapy. There were two grade 3 adverse events related to ISA101b. Grade 4-5 events related to… June 6, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2025 10 gene therapy companies you should know about …resolve vaso-occlusive events and is custom-designed to treat the underlying cause of sickle cell disease, which is a complex and progressive genetic disease associated with unpredictable and debilitating vaso-occlusive events…. November 14, 2025 - 15 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email